Documentos de Académico
Documentos de Profesional
Documentos de Cultura
METHODS
Blood samples are collected by venal puncture on live animal, as cleanly as possible, using sterile equipment, and with respect for the welfare of the animal. Use new needle and syringe for each animal. Dispose needles properly, Clean the puncture area with 70% alcohol, Handle animals calmly and using appropriate restraint,
Contd Although most techniques do not require large amount of blood it is preferable to collect at least 2.5mL of blood, but ideally 10mL in large animals, and 4-6mL in small animals.
Identify the sample with a permanent method and fill the sampling form at the time of sampling.
PRECAUTION
Preferentially use a vacutainer instead of a syringe If you have to transfer the blood from a syringe to a sample container, remove the needle first and transfer slowly and smoothly Do not shake the blood. Do not freeze whole blood.
Whole blood samples should be sent to the laboratory in an insulated container with ice at 4C.
PLASMA COLLECTION
Supernatent of unclotted blood Stored at -20 deg cel.
SERUM
SERUM= PLASMA CLOTTING FACTORS
PRESERVED BY REFRIGERATION
Introduction
Significant increase in blood transfusions for over the past 20 years in small animal medicin Most commonly used products: whole blood, packed red blood cells, plasma
Whole blood
PLASMA
Blood Types
Canine:
Thirteen canine blood types Designated by DEA (Dog Erythrocyte Antigen) & a number (DEA 1, DEA 2, DEA 3, etc). Important alleles of DEA 1: 1.1 and 1.2 DEA 1.1 positive (most common type) => universal recipient DEA 1.1 and 1.2 negative => universal donor
Blood Types
Feline
AB blood type system Types: A, B, AB (very rare) Naturally occurring alloantibodies to other blood groups => no universal donor in cats Type A cats: weak anti-B alloantibodies (weak reaction if transfused w/ B blood) Type B cats: high anti-A alloantibodies (severe reaction if transfused w/ A blood)
Predicts a transfusion recipients response to a donors RBCs and plasma Major cross-match
detects antibodies in the recipients plasma that can cause a hemolytic reaction to donor RBCs
Cross-matching
Minor cross-match
detects antibodies in the donors plasma that might react to recipients RBCs
CROSSMATCH
MAJOR
0.1
---
---
0.1
MINOR
---
0.1
0.1
---
DONOR CONTROL
0.1
0.1
---
---
RECIPIENT CONT.
----
---
0.1
0.1
Cross-matching - Canine
Dogs lack naturally occurring alloantibodies => a cross-match does not need to be performed on a patient receiving a transfusion for the first time Sensitization takes about 3 days
No cross-match needed if transfused within the previous 72 hours Cross-match becomes necessary 72 hours after a dog receives a transfusion
Cross-matching - Feline
All cats should be cross-matched if blood type is unknown or typing card unavailable
Donors
Canine
Good general health Between 1-8 years of age Minimum weight of 25 Kg (55 lb) - allows 450 mL of blood to be collected PCV should be 40% Current on vaccinations (DALPP, Rabies) Yearly exam and full CBC/Chemistry / heartworm antigen test Infectious diseases screening: .>Donors should not have had any previous transfusions because of risk to foreign RBC antigens and the development of antibodies
Dosages
ACD@15ml per 100 ml blood CPD and CPDA-1 @14ml per 100 ml blood at 2 to 6C, ACD whole blood and CPD whole blood can be used within 21 days after collection. (70% live rbc) In CPDA-1 35 DAYS Heparin less used
Administration
Blood products should be allowed to come to room temperature before administration Plasma is thawed by placing the plasma in a protective plastic bag and submerging it in a warm water bath not exceeding 98.6 F (37 C) - 30-60 minutes is generally adequate for thawing.
Administration
Several routes may be used for administering blood products
Intravenous (via 22-18g IVC) is the most common and effective, delivering blood products directly into circulation Intraosseous is also effective when vascular access is difficult or unsuccessful and often used for neonates Intraperitoneal
Plasma transfusion: for clotting factors 170-220 m in-line filter Smaller doses may be given via a 17um Hemo-nate filter Filters prevent protein debris, cellular debris, and blood clots from passing to the patient Blood products may be infused via free drip, syringe pump and fluid pump
Amount of donor whole blood (ml) required: = 90 x BW (kg) x Desired PCV- Actual PCV Donor PCV
Administration
Administration rates are variable Patients with massive hemorrhage may require a rapid transfusion Patients with chronic anemia need a slower infusion Blood components should always be infused slowly (1 mL/kg) for the initial 15-30 minutes while observing for transfusion reaction Subsequently, the rate may be increased to 5-10
mL/kg/hr
The blood product should be infused as quickly as the patient can safely tolerate, while maintaining detailed monitoring
Reactions
Immune-mediated
Hemolytic
Acute Delayed
Non-hemolytic
Non-immune-mediated
Reaction SIGNS
Chills, Fever, Urticaria, Tachycardia, Dyspnea, Nausea and vomiting, Tightness in the chest, chest , HHypotension, Bronchospasm, Angioneurotic edema, Anaphylaxis, Shock, Pulmonary edema, and Congestive failure
MANAGEMENT OF RXNS
Treatment depends on the severity Discontinuing thtransfusion
COMPLICATIONS
Hypocalcemia Fluid OVERLOAD Disease transmission COAGULOPATHIES(HEPARIN)
THANKS Moti.